ПАЦИЕНТ С МЕРЦАТЕЛЬНОЙ АРИТМИЕЙ НА АМБУЛАТОРНОМ ПРИЁМЕ У ТЕРАПЕВТА

ПАЦИЕНТ С МЕРЦАТЕЛЬНОЙ АРИТМИЕЙ НА АМБУЛАТОРНОМ ПРИЁМЕ У ТЕРАПЕВТА

Clinical observation of outpatients and deceased patients with atrial fibrillation, as well as implementing the Recommendations of the Russian Society of Cardiology and the European Society of Cardiology for the management of patients with atrial fibrillation were discussed during Moscow district th...

Full description

Bibliographic Details
Main Authors:	А. Л. Вёрткин, Е. А. Прохорович, А. С. Скотников, Е. А. Алгиян, М. А. Алексеев, А. У. Абдулаева
Format:	Article
Language:	Russian
Published:	SINAPS LLC 2013-06-01
Series:	Arhivʺ Vnutrennej Mediciny
Subjects:	atrial fibrillation thrombotic complications stroke acute myocardial infarction rivaroxaban warfarin antithrombotic therapy
Online Access:	https://www.medarhive.ru/jour/article/view/191

Similar Items

ВСЯ ПРАВДА О ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ
by: А. Л. Вёрткин, et al.
Published: (2013-08-01)

ПАЦИЕНТ С ТРОМБОЭМБОЛИЕЙ ЛЁГОЧНОЙ АРТЕРИИ НА ПРИЁМЕ У ТЕРАПЕВТА
by: А. Л. Вёрткин, et al.
Published: (2014-08-01)

ПРИМЕНЕНИЕ ПЕРОРАЛЬНЫХ АНТИКОАГУЛЯНТОВ ПРИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ: СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ И НОВЫЕ ВОЗМОЖНОСТИ
by: Г. И. Сторожаков, et al.
Published: (2013-04-01)

Changes in prescribing antithrombotic therapy in patients with atrial fibrillation and myocardial infarction in 2016-2019
by: K. G. Pereverzeva, et al.
Published: (2020-08-01)

Antithrombotic therapy with rivaroxaban in five patients with paroxysmal nocturnal haemoglobinuria and thrombotic events
by: Francesco Dragoni, et al.
Published: (2018-10-01)

An efficacy and safety study of rivaroxaban for the prevention of deep vein thrombosis in patients with left iliac vein compression treated with stent implantation (PLICTS): study protocol for a prospective randomized controlled trial
by: Miaomiao Li, et al.
Published: (2020-09-01)

НЕВРОЛОГИЧЕСКИЕ ПРОБЛЕМЫ КОМОРБИДНОГО ТЕРАПЕВТИЧЕСКОГО БОЛЬНОГО
by: А. Л. Вёрткин, et al.
Published: (2014-02-01)

Outcomes with aspirin and clopidogrel versus aspirin and rivaroxaban in infrainguinal endovascular revascularization for critical limb ischemia
by: B Nishan, et al.
Published: (2021-01-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
by: M. Yu. Gilyarov
Published: (2015-12-01)

RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov
Published: (2015-12-01)

Пациент с гипогликемией на приеме врача общей практики
Published: (2016-12-01)

КОНСУЛЬТАЦИЯ ТЕРАПЕВТА В ХИРУРГИЧЕСКОЙ КЛИНИКЕ: НАСКОЛЬКО ВАЖНА ЭТА МИССИЯ?
by: А. Л. Верткин, et al.
Published: (2012-10-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD
by: L. Y. Koroleva, et al.
Published: (2015-12-01)

PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD
by: L. Y. Koroleva, et al.
Published: (2015-09-01)

WARFARIN IN PATIENTS WITH CARDIOEMBOLIC STROKE
by: E. N. Dankovtseva, et al.
Published: (2015-12-01)

Thromboembolic recurrence frequency analysis in patients with deep vein thrombosis of lower extremities.
by: Sergyi Vasyliuk, et al.
Published: (2020-03-01)

Rivaroxaban – a safe therapeutic option in patients with antiphospholipid syndrome? Our experience in 23 cases
by: Ewa Haładyj, et al.
Published: (2016-07-01)

Signals of bleeding among direct-acting oral anticoagulant users compared to those among warfarin users: analyses of the post-marketing FDA Adverse Event Reporting System (FAERS) database, 2010–2015
by: Alshammari TM, et al.
Published: (2018-05-01)

Up-to-date potential of antithrombotic therapy in patients with coronary artery disease and diabetes
by: O. D. Ostroumova, et al.
Published: (2020-09-01)

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
by: Jan Beyer-Westendorf, et al.
Published: (2019-04-01)

Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions
by: James S Kalus
Published: (2013-04-01)

Antithrombotic Therapy in Patients with Coronary Artery Disease and Prior Stroke
by: Elisa Bellettini, et al.
Published: (2021-04-01)

Modern strategy of antithrombotic therapy in patients with coronary artery disease and atrial fibrillation after percutaneous coronary intervention
by: Yu. A. Karpov
Published: (2019-12-01)

ПРИМЕНЕНИЕ МУКОАКТИВНЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ В ПРАКТИКЕ ТЕРАПЕВТА
by: Ф. Т. Малыхин, et al.
Published: (2013-10-01)

Trends of ambulatory oral anticoagulant prescription in five major cities of China, 2012–2017
by: Zhenwei Yu, et al.
Published: (2020-03-01)

A Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin for Deep Vein Thrombosis (DVT) Treatment in Ethiopia
by: Derseh MT, et al.
Published: (2021-09-01)

Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy
by: D. A. Napalkov, et al.
Published: (2019-09-01)

Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF
by: Francis E. Ugowe, MD, et al.
Published: (2021-06-01)

Therapeutic aspects of the choice of antithrombotic therapy in patients with multifocal lesions of peripheral arteries
by: O Sh Oynotkinova, et al.
Published: (2019-09-01)

СОВРЕМЕННЫЙ ПОДХОД В ЛЕЧЕНИИ ОСТРОГО ТРОМБОЗА ГЛУБОКИХ ВЕН ПРЕПАРАТОМ РИВАРОКСАБАН
by: Е. П. Кривощеко в, et al.
Published: (2015-06-01)

New Possibilities of Antithrombotic Therapy of Patients with Peripheral and Widespread Atherosclerotic Lesion
by: A. L. Komarov, et al.
Published: (2018-05-01)

ВЗГЛЯД КЛИНИЦИСТА НА ДЕГУМАНИЗАЦИЮ ОТНОШЕНИЙ «ВРАЧ ПАЦИЕНТ»
by: В. М. Яковлев, et al.
Published: (2013-10-01)

Fact-finding survey of antithrombotic treatment for prevention of cerebral and systemic thromboembolism in patients with non-valvular atrial fibrillation in 9 countries of the Asia-Pacific region
by: Satoshi Ogawa, et al.
Published: (2012-02-01)

ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
by: A. Y. Rychkov, et al.
Published: (2016-01-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES
by: Ya. P. Dovgalevskiy, et al.
Published: (2016-01-01)

Comparison of Inflammatory Mediators in Patients With Atrial Fibrillation Using Warfarin or Rivaroxaban
by: Gabriela Lopes Martins, et al.
Published: (2020-07-01)

Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysis
by: Olivia S. Costa, et al.
Published: (2020-04-01)

Análise do grau de recanalização da trombose venosa profunda: estudo comparativo de pacientes tratados com varfarina versus rivaroxabana
by: Polyana Klomfass Piati, et al.

Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable
by: D. A. Napalkov, et al.
Published: (2018-11-01)

Cannot write session to /tmp/vufind_sessions/sess_8skr3e9l8smb6o3mqdknfd5r45